Figure 2.
Kaplan–Meier estimate of time to withdrawal from study treatment. Numbers below each week represent the number of patients remaining in the treatment period (16 weeks ± 1-week treatment window). Patient numbers drop after Week 15 through Week 17 due to the ±1-week treatment window at 16 weeks of study treatment. At Week 18, all subjects progressed to the follow-up period; therefore, none remained in the treatment period.
Abbreviations: BL, baseline; SCIT, subcutaneous immunotherapy.